Xenon Pharmaceuticals
XENE
XENE
220 hedge funds and large institutions have $3.16B invested in Xenon Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 67 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.4% less ownership
Funds ownership: 97.83% → 97.43% (-0.4%)
5% less capital invested
Capital invested by funds: $3.33B → $3.16B (-$166M)
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
Holders
220
Holding in Top 10
10
Calls
$25.6M
Puts
$4.73M
Top Buyers
| 1 | +$40.7M | |
| 2 | +$26.8M | |
| 3 | +$23M | |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$17.9M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$16.7M |
Top Sellers
| 1 | -$41M | |
| 2 | -$25.8M | |
| 3 | -$22.6M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$19.6M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$14.6M |